Revenue
$3.48B
Fiscal year ended 2026-06-27Operating income
$382.50M
Fiscal year ended 2026-06-27Free cash flow
$263.30M
Fiscal year ended 2026-06-27SCOTTS MIRACLE-GRO CO (SMG) reported revenue of $3.48B and net income of $73.90M for the fiscal year ended 2026-06-27. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from SCOTTS MIRACLE-GRO CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Agricultural Chemicals.
Income
| Metric | 2026-06-27 |
|---|---|
| Revenue | $3.48B |
| Cost of revenue | $2.36B |
| Gross profit | $1.11B |
| Operating income | $382.50M |
| Net income | $73.90M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $249.40M |
| Income tax expense | $94.50M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | $618.00M |
| General & administrative | Unavailable |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-27 |
|---|---|
| Cash & equivalents | $27.70M |
| Total assets | $3.17B |
| Current assets | $1.35B |
| Total liabilities | $3.38B |
| Current liabilities | $1.11B |
| Total equity incl. NCI | -$208.70M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $481.40M |
| Accounts receivable | $713.00M |
| Goodwill | $243.90M |
| Long-term debt | $1.84B |
| Accounts payable | $310.30M |
Cash flow
| Metric | 2026-06-27 |
|---|---|
| Operating cash flow | $369.30M |
| Capital expenditures | $106.00M |
| Investing cash flow | -$154.20M |
| Financing cash flow | -$237.60M |
| Net change in cash | -$23.40M |
| Stock-based compensation | $51.70M |
| Common dividends paid | $154.40M |
| Common share repurchases | $12.10M |
| Depreciation & amortization | Unavailable |
Derived
| Metric | 2026-06-27 |
|---|---|
| Free cash flow | $263.30M |
| Gross margin | 31.8% |
| Operating margin | 11.0% |
| FCF margin | 7.6% |
| SBC / revenue | 1.5% |
| Current ratio | 1.21x |
| Revenue YoY growth | 4.6% |
| Net margin | 2.1% |
| R&D / revenue | Unavailable |
| CapEx / revenue | 3.0% |
| Long-term debt / equity | Unavailable |
| Effective tax rate | 37.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SMG in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-Q · Filed 2026-02-04View SEC filing
10-K · Filed 2025-11-25View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.